REDUCED SYNTHESIS OF TISSUE PLASMINOGEN-ACTIVATOR BY VASCULAR ENDOTHELIUM DURING ACUTE MYOCARDIAL-INFARCTION

被引:3
|
作者
NORRIS, RM [1 ]
OCKELFORD, PA [1 ]
CROSS, DB [1 ]
RIVERS, JT [1 ]
SMITH, JM [1 ]
TAKAYAMA, M [1 ]
WHITE, HD [1 ]
机构
[1] AUCKLAND HOSP,DEPT HAEMATOL,AUCKLAND 3,NEW ZEALAND
来源
关键词
TISSUE PLASMINOGEN ACTIVATOR; CORONARY THROMBOSIS; VONWILLEBRAND FACTOR;
D O I
10.1111/j.1445-5994.1992.tb02122.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We measured levels of tissue plasminogen activator (t-PA) antigen in 100 patients within six hours of the onset of acute myocardial infarction, in 34 patients with chronic angina but no recent infarction, and in 36 normal subjects. We also assayed von Willebrand factor in the acute patients and in the normal subjects. Measurements were repeated in 40 acute patients at three weeks after myocardial infarction. Although resting levels of t-PA antigen were not significantly different from normal during myocardial infarction, the capacity of the vascular endothelium to release t-PA after five minutes of venous occlusion was impaired (p < 0.01). The acute phase vessel wall release of von Willebrand factor was increased during acute infarction (p < 0.01). We conclude that impairment of t-PA production is associated with acute coronary thrombosis, although it is not possible to differentiate between a causative role or a secondary response due to exhaustion of the t-PA producing mechanism.
引用
收藏
页码:261 / 264
页数:4
相关论文
共 50 条
  • [31] THE RELATIVE BENEFIT AND RISKS OF INTRAVENOUS STREPTOKINASE AND TISSUE PLASMINOGEN-ACTIVATOR IN ACUTE MYOCARDIAL-INFARCTION
    ROSS, AM
    RISK/BENEFIT ANALYSIS FOR THE USE AND APPROVAL OF THROMBOLYTIC, ANTIARRHYTHMIC, AND HYPOLIPIDEMIC AGENTS, 1989, : 23 - 28
  • [32] CORRELATION BETWEEN BASE-LINE PLASMINOGEN-ACTIVATOR INHIBITOR LEVELS AND CLINICAL OUTCOME DURING THERAPY WITH TISSUE PLASMINOGEN-ACTIVATOR FOR ACUTE MYOCARDIAL-INFARCTION
    SANE, DC
    STUMP, DC
    TOPOL, EJ
    SIGMON, KN
    KEREIAKES, DJ
    GEORGE, BS
    MANTELL, SJ
    MACY, E
    COLLEN, D
    CALIFF, RM
    THROMBOSIS AND HAEMOSTASIS, 1991, 65 (03) : 275 - 279
  • [33] EFFECTS OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND ANISOYLATED PLASMINOGEN STREPTOKINASE ACTIVATOR COMPLEX ON MORTALITY IN ACUTE MYOCARDIAL-INFARCTION
    HELD, PH
    TEO, KK
    YUSUF, S
    CIRCULATION, 1990, 82 (05) : 1668 - 1674
  • [34] ENDOGENOUS TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND RISK OF MYOCARDIAL-INFARCTION
    RIDKER, PM
    VAUGHAN, DE
    STAMPFER, MJ
    MANSON, JE
    HENNEKENS, CH
    LANCET, 1993, 341 (8854): : 1165 - 1168
  • [35] ANALYSIS OF COAGULATION AND FIBRINOLYSIS AFTER THROMBOLYTIC THERAPY WITH HUMAN TISSUE PLASMINOGEN-ACTIVATOR, MUTANT TISSUE PLASMINOGEN-ACTIVATOR, OR UROKINASE IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION
    IWADE, K
    AOSAKI, M
    OHKI, K
    MATSUMURA, K
    KIMATA, S
    HOSODA, S
    THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 1337 - 1337
  • [36] FIBRIN METABOLISM IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION DURING AND AFTER TREATMENT WITH TISSUE-TYPE PLASMINOGEN-ACTIVATOR
    RING, ME
    BUTMAN, SM
    BRUCK, DC
    FEINBERG, WM
    CORRIGAN, JJ
    THROMBOSIS AND HAEMOSTASIS, 1988, 60 (03) : 428 - 433
  • [37] PHARMACOKINETICS OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR DURING ACUTE MYOCARDIAL-INFARCTION IN MEN - EFFECT OF A PROSTACYCLIN ANALOG
    KERINS, DM
    ROY, L
    KUNITADA, S
    ADEDOYIN, A
    FITZGERALD, GA
    FITZGERALD, DJ
    CIRCULATION, 1992, 85 (02) : 526 - 532
  • [38] COAGULATION, FIBRINOLYSIS AND VISCOSITY DURING THROMBOLYTIC THERAPY OF ACUTE MYOCARDIAL-INFARCTION WITH RECOMBINANT TISSUE PLASMINOGEN-ACTIVATOR (RTPA)
    DOUGLAS, JT
    HILLIS, WS
    DUNN, FG
    HOGG, KJ
    BURNS, JMA
    GEMILL, JD
    LOWE, GDO
    BRITISH JOURNAL OF HAEMATOLOGY, 1988, 69 (01) : 134 - 134
  • [39] HEMORRHAGIC COMPLICATIONS ASSOCIATED WITH THE USE OF INTRAVENOUS TISSUE PLASMINOGEN-ACTIVATOR IN TREATMENT OF ACUTE MYOCARDIAL-INFARCTION
    CALIFF, RM
    TOPOL, EJ
    GEORGE, BS
    BOSWICK, JM
    ABBOTTSMITH, C
    SIGMON, KN
    CANDELA, R
    MASEK, R
    KEREIAKES, D
    ONEILL, WW
    STACK, RS
    STUMP, D
    AMERICAN JOURNAL OF MEDICINE, 1988, 85 (03): : 353 - 359
  • [40] CARDIAC MORPHOLOGIC FINDINGS IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION TREATED WITH RECOMBINANT TISSUE PLASMINOGEN-ACTIVATOR
    GERTZ, SD
    KALAN, JM
    KRAGEL, AH
    ROBERTS, WC
    BRAUNWALD, E
    AMERICAN JOURNAL OF CARDIOLOGY, 1990, 65 (15): : 953 - 961